Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01746420 · ClinicalTrials.gov registry record · Phase 2

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

A Phase 2 study of Lateral Epicondylitis, sponsored by BioMimetic Therapeutics.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target
6
Study locations

NCT01746420 is a Phase 2 study of Lateral Epicondylitis that has completed, run by BioMimetic Therapeutics. The registered enrollment target is 100 participants, below the 113-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (12% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01746420, a Phase 2 study of Lateral Epicondylitis, has completed, sponsored by BioMimetic Therapeutics.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to determine whether recombinant human platelet-derived growth factor (rhPDGF-BB) Injection is effective in the treatment of lateral epicondylitis (tennis elbow).

Conditions Studied

Lateral Epicondylitis

Interventions

  • DRUG Placebo
  • DRUG rhPDGF-BB Injection

Study Locations (6)

Arizona

  • Arizona Research Center - Phoenix
  • Tucson Orthopaedic Institute - Tucson

Florida

  • Coastal Orthopedics & Sports Medicine - Bradenton
  • Foundation for Orthopaedic Research and Education - Tampa

Arkansas

  • NEA Baptist Clinic - Jonesboro

North Carolina

  • OrthoCarolina - Charlotte

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-12-12
Est. Completion 2014-10-21
Phase Phase 2

Sponsor

BioMimetic Therapeutics

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01746420

The ClinicalTrials.gov registry entry for NCT01746420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (12% lower). The listed sponsor is BioMimetic Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lateral Epicondylitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01746420 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Florida, Arkansas.

Frequently Asked Questions

What is clinical trial NCT01746420 about?

NCT01746420 is a clinical study titled "Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis". The purpose of this study is to determine whether recombinant human platelet-derived growth factor (rhPDGF-BB) Injection is effective in the treatment of lateral epicondylitis (tennis elbow).

What is the current status of trial NCT01746420?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2012-12-12. Estimated completion is 2014-10-21.

What conditions does trial NCT01746420 study?

This clinical trial studies the following conditions: Lateral Epicondylitis.

What interventions are being tested in trial NCT01746420?

The interventions under investigation include: Placebo (DRUG), rhPDGF-BB Injection (DRUG).

Who is sponsoring clinical trial NCT01746420?

This trial is sponsored by BioMimetic Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01746420 being conducted?

This trial has 6 study locations across Arizona, Arkansas, Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lateral Epicondylitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lateral Epicondylitis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.